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The SHARE project [1] on developing a roadmap for the adoption ofhealthgrids in the European Un-
ion focuses one of its work packages on a detailed examination of the legal issues which are relevant
to the adoption of grid technologies in the health sector. The project looks atlegal issues around data
protection, product and service liability and also intellectual property rights.
This chapter focuses on just one of those legal aspects -data protection. ThrOUgh a detailed examina-
tion of the European Data Protection Directive it provides an interpretation of the Directive for the
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Most healthcare systems in the developed world are facing multiple challenges in their attempt to
maintain an acceptable level of Cale for their citizens. The principal challenges are often experienced
and expressed in economic terms, e.g. as issues of total cost, capacity and responsiveness, and alloca-
tion of limited resources. ln an attempt o rise to these challenges health systems have increasingly
looked to information technology to help, among ailier things, optimize the distribution and use of
resources, to reduce queues and waiting times, to record and so avoid errors, and to provide modem















However, health care systems in Europe have experienced limitations in the application of traditional
information networks and technology in healthcare. Governments have naturally focussed on the tech-
nical issues that are reasonably weIl understood, even if solutions are Dot always easy to obtain: ro-
bustness of networks, scalability of systems, readiness to handle a very large volume of data. How-
ever, in many respects, these reproduce in the technology some of the problems of the traditional pa-
per-driven systems: inflexibility, rnaldistribution of resources, failure to understand the needs of medi-
cal practitioners, failure to support effective collaboration, and an ultimately simplistic equation of
quality with 'choice', while minimal provision is made for just-over-the-horizon future technologies
such as genomic medicine and individualized prescribing.
ln the face ofthese challenges, acomputational innovation, 'grid' technology, or the grid, has become
available to clinicians in the last few years, first as a research tool and then, in the not-too-distant fu-
ture, as a serious healthcare infrastructure. The grid is Dot one technology but many, and the use of the
singular is somewhat misleading, but it is convenient inasmuch as it echoes 'the intemet' to which it is
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closely related. Just as the intemet, or more precisely the World Wide Web, bas provided a massive
information platform whose exploitation is limited only by economics (and, in some cases, politics)
grid technology promises to scale this up to the provision of unprecedented computational power,
online storage and collaboration opportunities. The informatic grid approaches the provision of com-
pQtational, information and communication services throUgh resource sharing in a seamless and trans-
parent manner, much as the electricity 'grid' provides power to any device plugged into it, irrespective
ofits purpose or design. Grid computing aims at the provision of a global ICT infrastructure that will
e~ble a coordinated, flexible and secure sharing of diverse resources, including computers, applica-
tions, data, storage, networks, and scientific instruments across dynamic and geographically dispersed
organizations and communities (sometimes known as 'virtual organizations' or 'VOs'). Grid tech-
nologies promise to change the way organizations tackle complex problems by offering unprecedented
opportunities for resource sharing and collaboration. Just as the World Wide Web transformed the way
we exchange information, the grid concept akes parallel and distributed computing to the next level,




However, the adoption of grids for healthcare is still in its infancy. There are many reasons to this
situation. A first obvious reason is that grid technology is still immature and is neither robust nor se-
cure enough to offer the quality of service required for routine clinical use. Another important reason
is that aIl grid infrastructure projects are deployed on national research and education networks which
are bath separate from the networks used by healthcare structures and very much less secure than
they need to be. Another potentiai obstacle is the legal fraIÏ1ework in the EC member states which
has to evolve to allow the transfer ofmedical data on a European healthgrid. We must also not forget
that grids, despite their virtual nature, still require human beings to make choices. Accordingly the
economic and benefit case for the use of grids must be made and finally the real work environments






Accordingly the SHARE project bas been co-fmanced by a nurnber of organisations and the European
Commission's research and technological development funds in order to develop a roadmap to en-
hance Grid adoption in the health sector throughout he European Union. The project as a whole looks
at a number of issues -in particular at some key use cases in the life science and medical research[2],
in fuis chapter however we look in more detail at the legal and regulatory issues which need to be ad-
dressed in order to promote the adoption of grid technology in the European health sector.
0
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Grid technologies, by allowing for more comprehensive and faster creation, monitoring, and update of
the medical content of prevention and health promotion schemes, are expected to play an important
foie in creating more efficient, patient centred systems of healthcare which are able to sustain those
cote values. It is important therefore that in order to under stand the potential of healthgrids and in
order to adopt sensible roadmaps for research on grids and their implementation in the health sector




A comtnon factor amongst many of the connected health tools, whether they use grid technology or
more cQnventional networks, is that they store, process, forward and share data. Some of that data is
adminisJrative, some related to objects, such as in radio-frequency identification based cracking of
devices" but a great deal of the data is the personal data of patients. Healthcare professionals know
they have a duty of confidentiality and a duty of care -they want to exercise both fully in order to
provide a safe environment in which patients are treated with due respect for their privacy. The duty to
provide care is undoubtedly served by sharing patient records, providing on-Ille support to colleagues
and eveQ giving direct support o patients in their homes via the internet but how does it sit with
the co-eJ(jsting duty of confidentiality?
~e purpose of fuis chapter is ta explore the nature of the European response ta medical privacy
~ough ..detailed examination of the data protection directive. However, data privacy is not the only
legal iss4e which should be addressed in roadmapping healthgrids. It is also vitally important ta as-
~ess the extent to which product and services liability is adapted to meeting the challenges of health-
grids, as weil as considering the wider legal-economic issues such as intellectual property rights. The
SHARE project also looks in some detail at the legal issues arsing from the shared intellectual prop-
erty of data in healthgrids and of healthgrids themselves. This however is work which will be con-
ducted in the second year of the project and as such is not Jet ready to be reported.
1.2.2. European Data Protection
The key principles relevant o the processing of persona! data were flrst established by the Council of
Europe [3], and further developed in Directive 95/46/CE of the European Union -the European data
Protection Directive [4]. The latter is the major source of legislation, however, the Recommendation
made by the Council of Europe is also of importance for the healthcare sector and for the use of grid
technology in that sector, since it focuses on the field ofmedical data and scientific research.
The Directive provides a general framework for the protection of privacy with respect a the process-
ing of persona! data in its widest sense. It is important o note here that the Directive is based on the
privacy of processing of data, not privacy per se. Thus, the Directive does not confer any special rights
ofprivacy ofan individuaI which might be covered in a Member State's constitution, but rather it pro-
vides rules about how personaI data may be processed so that the processing itself does not infringe
the privacy of an individual. Within the terms of the directive a suitable level of privacy is to be af-
forded to aIl data related to a natural person, whether the context of such information is the private,
public or professionaI life of the individual. The Directive thus goes beyond the concept of private life
and intimate detail.
The primary purpose of the Directive is to allow the free flow of persona! data between the Member
States of the European Union, in order to facilitate the establishment and the functioning of the inter-
nai market. While its secondary purpose is to protect the fundamental rights and freedoms of natural
persons and in particular their right to privacy with respect o the processing of their personal data.
The protection granted by the Directive does, however, go further than the protection of the natural
person's intimacy, i.e. generally speaking the protection of each natural person private life. It applies
more particularly to any sensitive data relating to natural persons such as data conceming health -
including mental health.
To what data does the data protection directive apply?
ln deciding if the Directive applies to a particular set of data one must therefore fIrst ask if the data
allow the identification of a particular natural person and second if the data are going to be processed
by someone (a legal or natural person). The basic principle here is that if a piece of information (a
laboratory result) tan be linked ta a person either by reasonably simple means or even by or with the
help of a third party, then the data are considered as identifiable and therefore in the scope of the Di-
rective. It should be noted that this concept is usually construed quite widely. Thus, if the information
refers ta a group or if it is so complete or so unique as to make it applicable ta only a very small num-
ber of people (e.g., disease profile, age, gender, postcode, profession ail held together) then the data
could bé classifÎed as identifiable even if no actual identifier were used.
To whom does the data protection directive it apply?
The data protection mies are addressed primarily to the data controller -fuis is the legal name of the
persan who decides the purpose and the means of the processing. This persan bas the legal duty to
ensure that data are handled appropriately in order to ensure the right level of privacy. The data con-
troller is usually a senior staff and whose is officially named as the data controlled by organisation's
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goveming body. Althoug!1 the controller is always a natural (real) persan, she does not necessarily
have to belong ta: a fonnally constituted body.
ln the case of ahealthgrid several doctors or scientists may therefore be separately defmed as data
controllers -since the data contained in one healthgrid application might have been collected
thrOUgh several âifferentstudies or have been extracted from several different patient data sets.
What are the main dulies of a data controller?
Any personal data that the controller needs to process for the purposes of rus or her professional or
other activity must meet certain level of quality. This means that the controller must comply with the
Directive's princip\es conceming data collection and data processing.
First, fuis means the data may only be collected for specified, explicit and legitimate purpose. ln
practice that will require thecontroller to derme clearly and precisely the purpose(s) for which the data
are to be processed. The conr;roller will therefore have to noti1'y the relevant national authority that she
is intending to colldct personal data and must set out clearly what data will be collected and for what
reason. The controller should also be able to explain the purpose and process of the data collection and
handling to the data subject.
Second, the purpose of the processing must be legitimate. The Directive lists the general conditions
under which the pro<lessing will be presumed as legitimate and the nationallegislation further detines
what types of data prpcessingare legitimate.
We noted earlier that\ the ovemrching purpose of the Directive is to protect privacy within the context
of the growth of the ~temal market. This means that ta be legitimate the interests in the data process-
ing must outweigh the interests of the data subject in excluding the processing of the data. Medical
data processing is usu~lly legitimate processing because the data subject will have a significant interest
in her health data bei1\1g shared with appropriate professionals if the sharing of the health information
will allow better and safer healthcare delivery.
Generally a controllermay only process personal data for the purpose which was given when the data
were first collected. ln: some cases the controller May want ta re-use the data for another purpose, this
will only be legal if th~ secondary use falls under the uses covered by the nationallegislation. ln many
Member States such re~use is permitted if it is for statistical, scientific or historical purpose.
Furthermore, the data ~oUected should be adequate for he stated purpose but not excessive. If a re-
searcher collects data $ order W carry out a specified research project, she May not collect other data
which are not necessary for the study in band but might be useful at some later date. Once the data are
collected, the controller must k~ep them up-to-date for as long as they are needed for the specified
purpose, but should not keep !hem longer than necessary, and must be rendered anonymous or de-
stroyed the data when the pre-detined purpose of processing bas been achieved
I
lf the data are to be processed by a third party -a data processor -fuis means in practice that the con-
tract between the data cpntroller and the data processor must include a clause that the data processor
shall act only on instruction of 4ata controller and that she is also legally responsible in case of any
breach of data confidentlality.
e controller also bas a duty to ensure that data are stored and processed securely by taking appropri-
te technical and organi~tional measures to ensure the security and confidentiality ofperson identifi-
ble data. According to A;rticle 11 of the Directive, the controller bas the obligation to ensure the secu-
'ty of the personal data processed, meaning that he must ensure that the data are not lost, altered, or
ccidentally destroyed. IJiI order to achieve those two purposes, the controller must implement appro-
riate technical and organisationalmeasures to protect personal data against, for instance, accidental or
nlawful destruction or !iccidental loss, alteration, unauthorised disclosure or access, in particular
here the processing invQlves the transmission of data over a network, and against ail other unlawful
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forms of processing [5]. ln other words, the controller bas ta construct bis system ta render it suffi-
ciently secure for the processing of personal data.
This rnight also imply that in a healthcare setting a structural reorganisation of the hospital or research
institute is undertaken to ensure the confidentiality and the security of the data processed. This rnight
include the appointment of a data protection officer in charge of the data protection issues. On the
other hand, technical measures could include restricted access to the databases to authorized persons
and the utilisation of software protecting the system against viruses or hacking.
--
Processing nominative or identifiable related data in medical research grid would be legitimate if
researchwere given as the purpose of the processing at the time of collection. However, the con-
troller of a healthgrid must ensure that nominative or identifiable data are not kept for longer than
necessary for the originally defined purpose -in a longitudinal of multi-purpose research study it
willtherefore usually be necessary to keep the data in an anonymous or pseudonymous form. Fur-
thermore where nominative or identifiable data are stored reasonable steps must be taken to rude
the true identity of a data subject. Given that the nature of grids is to share the data -often over
nationalboundaries -the steps taken to protect the data must be commensurate with the processing
technology.1n other words,because agrid is a bi-tech application, state of the art security technol-
ogymust be used to protectthat data storedand pro~essed in the grid.
Are aU personal data treated in the same way by the Directive?
A general principle provides that the level of protection offered by the Directive ta personal data de-
pends not on the information content, but on the purpose of the data processing. ln other words, the
potential or actual infringement for the fundamental rights and freedoms of the data subject ofprivacy
and autonomy will be assessed on the basis of the purpose of the processing ofpersonal data.
However, a key indicator remains in the nature of the data. Some data are considered as sensitive and
in need of special protection. This is the case of persona! data revealing racial or ethnic origin, political
opinions, religious or philosophical beliefs, trade-union membership, as weIl as data conceming health
or sex life and judicial data. For these data the protection depends on the content of the information
and on the purpose of the data processing. Therefore article 8 of the Directive prohibits the processing
medical and other sensitive data.
However, the ban is not absolute. The directive sets out a nurnber of cases in which the collection and
processing of medical data may be legitimate. As a result the national legislation of the Member
States will allow processing of medical data if:
The controller bas obtained the explicit informed consent of the data subject; or
If the data are collected to protect the vital interest of the data subject or of another person
when the data subject is physically or legally incapable of giving bis consent; or;
The data are collected for the purposes of preventive medicine, medical diagnosis, the provi-
sion of care or treatment or the management of health-care services and if the data are proc-
essed by a health professional subject to the obligation of professional secrecy or by another
person also subject o an equivalent obligation of secrecy.
The Directive provides the possibility for the Member States to add exemptions for reasons of substan-
tial public interest which could be subject to further specific safeguards, such as the authorisation of
the national supervisory authority. Thus, a national transposition of the Directive might allow for the
adoption of a national exemption for scientific research or for social security reason.
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According to the exemptions to article 8, as listed in its paragraphs and sub paragraphs, a health-
grid containing nominative or identifiable health data will be legal in terms of data protection
only if the explicit consent of the data subject was obtained before the data were collected. If this
didnot happen then the data in the grid a handled by a medical doctor AND the purpose of the grid
is the further preventive medicine, medical diagnosis, the provision of care or treatment or the
management of health-care services. If the persan handling the data is not a medical doctor but a
research scientist he or she will have to be contractually bound in bis or ber employment contract o
maintain the confidentiality of the data. The only case in which these criteria need not be met is
where the Member State in question has passed specitic legislation which provides different
terms for data collection and processing for the purposes of medical, scientitic or historical
research
What rights does the Directive give to the data subject?
The general purpose of the Directive is to facilitate sharing of data in the context of the internai market
whilst allowing the data subject o retain appropriate control over the data. Accordingly the Directive
requires that data subjects bas access to infonnation about the type of data held and the purpose for
which it is processed and further the data subject must be allowed to have any errors in the data recti-
tied or, under some conditions, to object to the processing and have it stopped.
A distinction is made between cases where the data are collected directly from the data subject and
where they are collected indirectly. If the data are collected directly from the data subject he control-
1er must provide at least identity (name, address, denomination or trade Dame, etc.) and a description
of the purposes of the processing. These purposes have ta be specified and explicit, which means that
a precise description of the scientific or the statistical project must be given. The processing of sensi-
tive data or medical data normally requires the provision of further information. Guidelines provide,
for example, that in case of genetic analysis, the data subject should be informed about the objectives
of the analysis and about he possibility ofunexpected findings [6].
When personal data have not been obtained directly from the data subject, the controller should, before
considering the way of processing these persona! data or the right rime to inform the data subject, as-
sess whether they comply with the requirements for re-use of data [7].
Moreover, the duty of infonnation does not apply when data are indirectly collected for processing for
statistical purposes or for the purposes of historical or scientific research, if the provision of such in-
formation is impossible or would involve a disproportionate ffort.
AlI data subjects have the right to request specific information about their own personal data that are
processed by the controller. Moreover, where medical data are processed, data subjects MaY ask a
healthcare profess~onal to exercise their access right. Upon request, the controller will then have to
provide the data subjects with information such as whether or data processing data relating to them is
taking place. He will also have to inform them about the purpose of the processing, the categories of
data and the data being processed, the recipients or categories of recipients to whom the data are dis-
closed and the source of the data. However, the Directive allows Member States to exempt the control-
1er from respecting the data subject's access right where the purpose of the processing is scientific
research, or when data are kept in personal form for a period which does not exceed the period neces-
sary to create statistics. The Directive, however, subjects the granting ofthat exemption to the condi-
tion that there is clearly no risk of breach of the data subject's privacy. Moreover, data May not be
used in order to take measures or decisions regarding any particular individual.
Under the Directive, a data subject has the right to ask for data to be corrected, erased or blocked
where their processing does not comply with the provisions of the Directive [8]. This is particularly
the case where personal data are incomplete or inaccurate. This right means that the controller must
correct, erase or block the data as required by the data subject, in a reasonable period. Blocked data
cannot further be processed, used, or communicated without the data subject's consent. ln addition, if
the controller bas disclosed the data to third parties, he has to notify them about any correction, erasure
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or blocking carried out. This notification of correction, erasure or blocking of data does not have to be
perfonned ifit proves to be impossible or involves a disproportionate ffort [9].
The Directive allows Member States to exempt the controller from the obligation to respect the data
subject's right of correction in case of processing for purposes of scientific research, or when data are
kept in personal form for a period which does not exceed the period necessary for the sole purpose of
creating statistics[lO]. Furthermore the Directive provides that the data subject has the right to abject
to the processing ofhis data. When there is a legitimate objection to the data processing, the controller
may no longer process the concemed data or communicate them to recipients, and must ensure they are
erased [11].
What are the implications for Cross-Border Data Sharing?
Healthgrids provide doctors, researchers and health system planners the opportunity to support areas
of healthcare such as medical imaging and image processing; modelling the hurnan body for therapy
planning; pharrnaceutical research and development; epidemiological studies; and genomic research
and treatment development. However, in order to be truly effective such grid applications must to
draw together huge arnounts of data frOID disparately located computers -which of course irnplies data
sharing across jurisdictions and the sharing of responsibilities by a range of different data controllers.
Nationallegislations of the different EU Member States should be harmonised by now, and the trans-
fers of personal data between these Member States should not create any problem. Thus, a data con-
troller established on the territory of one Member State should not fear by transferring the data he
processed to another controller established in another Member State, that these data would not be cor-
rectly protected as the second Member State does not provide for the same level of protection of per-
sallal data as the first one.
This would be the case if aIl Member States had transposed the Directive in the same way. But differ-
ences are aIready to be found in the member States' legislations as regards the defmitions ofkey con-
cepts of the Directive such as 'personal data', 'processing' or 'controller'. Moreover, the Directive
itself allows the Member States 10 «adopt legislative measures to restrict the scope of the obligations
and rights provided for in Articles 6 (1), 10, Il (1), 12 and 21 when such a restriction constitute a






There might thus be differences in the level of protection granted to personal data between the EU
Member states, which might be a problem for the implementation of the Healthgrid technology on the
whole te~tory of the European Union. However, it is important to note that even ifthere are differ-
ences in the levels of protection of personal data between the Member States, these differences are of
minor imp(j)rtance, as the implementation of the Directive already ensures a high level of protection for
personal data. These differences in the levels of protection of personal data between the Member
States can not even constitute barriers to data transfers as Article l, paragraph 2 of the Directive pre-
scribes: 1
"Member $tates shall neither restrict nor prohibit thefreeflow ofpersonal data between Member
States for r~asons connected with the protection afforded under paragraph 1 (i.e. the protection of
data subjects' fundamental rights and freedoms)".
This is not ia1ways the case as what regards the transfer of persona! data towards other countries 10-
cated outsiqe the European Union and the European Economic Area (EEA) which govemed by spe-
cific conditions [12] that need to be met in addition to the requirements for the communication of per-
sona1 data to third parties as ana1ysed above.
The general rule is that the controller should refrain from transferring persona! data to a recipient 10-
cated in no,-EEA countries. However, the Directive provides that if the data subject bis consent un-
ambiguouslr to the proposed transfer; or the transfer is necessary for the performance of a contract
between the data subject and the controller (as might be the case for healthcare) or if the transfer is
necessary fqr the conclusion or performance of a contract concluded in the interest of the data subject
between the controll~r and a third party (as might be the case in medical research undertaken for aspe-
tic patient ~ group of patients or the transfer is necessary in order to protect the vital interests of the
data subject;
Moreover, the Directive states that Member States may authorise a transfer or a set oftransfers ofper-
sonal data t\) a third country that does not ensure an adequate level of protection of personal data,
where the cqntroller adduces adequate safeguards through appropriate contractual clauses between the
sender and the recipient of the personal data. ln this frame, the European Commission proposes stan-
dard contracJ;ual clauses that ensure an adequate level of protection of transferred personal data.
However, EUropean Directive does not set specific conditions for the transfer of medical data to non
EU (and noq EEA) countries, but the Recommendation No. R (97) 5 of the Committee of Ministers to
Member Sta~s on the protection ofmedical data, adopted on 13 February 1997, does s~. It establishes
additional rules for the transfer of medical data to a country which does not have an eqwvalent level of
protection offmedicaidata as the one granted on the territory of the European Union.
Furthermore, some countries, such as Argentina, Isle of Man, Guemsey and Switzerland, have been
recognised by the European Commission as ensuring an adequate level of protection. This means that
the Europeaij Commission bas decided that these countries have a level of protection of personal data
in some waYlequivaient to the one available in the Member States of the European Union. The transfer
of data to companies or other legal entities located on the territory of the United States which adhere to
the US Depltrtment of Commerce's Safe Harbour Privacy Principles is also allowed. The European
Commission 1 moreov~r allows the transfer of personal data to recipients located on the territory of
Canada, provided that these recipients are subject o the Canadian Persona! Information Protection and
Electronic Documents Act (also called the 'PIPED Act').
1.2.3. Conclusion
From the dis'tussion of the basic concepts and duties of the data Protection Directive and its impact on
healthgrids s\1ows that when healthgrids are used for treating patients or planning care the require-
ments to of the legislation provide that so long as the data subject has consented or the data collected
and processecli by medical professionals the balance of rights weighs in favour of data collection -that
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